ALLIANCEBERNSTEIN HOLDING L.P. (AB) [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Appointed director
CC transcript
Asset disposition
Quarterly results

ALLIANCEBERNSTEIN HOLDING L.P. (AB)

Create: Alert

All | News | Filings

Date Filed	Type	Description
04/29/2021	GN	AB Science today announced that its masitinib Phase 2B/3 study (AB12003) in metastatic castrate-resistant prostate cancer (mCRPC) met its predefined primary endpoint
04/29/2021	GN	AB Science annonce aujourd'hui que l'étude de phase 2B/3 (AB12003) du masitinib dans le cancer de la prostate métastatique hormono-résistant (mCRPC) a atteint son critère d'évaluation principal prédéfi
04/06/2021	GN	AB Science announces the signing of an exclusive licensing agreement with the University of Chicago to conduct research for the prevention and treatment of Covid-19
04/06/2021	GN	AB Science annonce aujourd'hui la signature d'un accord de licence exclusif avec l'Université de Chicago sur la prévention et le traitement de la Covid-19
03/31/2021	GN	AB Science provides an update on the expected timelines for the read-out of its masitinib Phase 3 study (AB12003) in metastatic castrate-resistant prostate cancer
03/08/2021	GN	AB Science announces that a new independent publication confirms the role of masitinib as a potential therapy in neurodegenerative disorders including Alzheimer's Disease

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy